You searched for: UsDsign
OssDsign raises SEK 158 million in a private placement
OssDsign changes CEO for increased US focus
OssDsign announces that CEO Morten Henneveld will leave his position at the end of 2025 to make way for a...
Strong growth for OssDsign – the share is rising
Just over a year after its strategy shift, OssDsign can summarize a strong 2024 as a pure orthobiology company. Net sales for the full year landed...
OssDsign receives expanded FDA approval
OssDsign continues to reap success with the Catalyst bone graft. The company recently announced that it has reached the milestone of 2 treatments in...
Uppsala's life science sector continues to grow
With more than 100 companies with a combined turnover of over SEK 33 billion, life science has become the Uppsala region's largest growth industry.
Emplicure's Chairman of the Board comments on the CEO change
Emplicure starts the fall with a new CEO and an approved application for a clinical pharmacokinetic study. BioStock spoke with...
BioStock Investor Meeting: Interview with OssDsign
In connection with the BioStock Investor Meeting in Stockholm, BioStock's reporter was visited by Anders Svensson, CFO at OssDsign. Svensson...
BioStock Investor Meeting: OssDsign presents
Medical technology company OssDsign develops and manufactures regenerative implants and patient-specific solutions for the treatment of bone defects. CFO Anders Svensson participated in...
BioStock Investor Meeting September 14
On September 14th, it was time again for the BioStock Investor Meeting, where life science companies from various therapeutic areas presented their...
Karolinska Development increases its net asset value
Investment company Karolinska Development recently submitted its report for the first quarter of 2022. The company reports an increased net asset value of SEK 4,80...
Fully recruited study with OssDsign Catalyst
Karolinska Development's portfolio company OssDsign has now recruited all patients to the TOP FUSION clinical study, which evaluates the effect and...
OssDsign includes first patient in the US
The KD company OssDsign is expanding its presence in the US. The company now announces that the first patient has been included in PROPEL, the company's...